Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen Kangtai Biological Products Co., Ltd.
  6. Financials
    300601   CNE100002Q33

SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.

(300601)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 22 76956 644119 40774 459--
Entreprise Value (EV)1 22 76956 644119 40771 01171 22169 952
P/E ratio 51,1x97,5x173x65,2x39,7x28,5x
Yield ---0,24%0,41%0,63%
Capitalization / Revenue 11,3x29,1x52,8x21,3x13,3x10,2x
EV / Revenue 11,3x29,1x52,8x20,3x12,7x9,56x
EV / EBITDA -76,3x135x52,2x30,8x21,8x
Price to Book 12,5x20,6x16,0x8,69x7,32x6,02x
Nbr of stocks (in thousands) 636 350645 221684 282686 957--
Reference price (CNY) 35,887,8175108108108
Announcement Date 02/26/201902/28/202004/29/2021---
1 CNY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 2 0171 9432 2613 4905 6047 320
EBITDA1 -7428821 3602 3163 208
Operating profit (EBIT)1 4816587751 2712 1052 932
Operating Margin 23,9%33,8%34,3%36,4%37,6%40,1%
Pre-Tax Profit (EBT)1 4896637721 2672 0722 809
Net income1 4365756791 1321 8272 477
Net margin 21,6%29,6%30,0%32,4%32,6%33,8%
EPS2 0,700,901,011,662,733,80
Dividend per Share2 ---0,260,450,68
Announcement Date 02/26/201902/28/202004/29/2021---
1 CNY in Million
2 CNY
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4
Net sales1 1 4321 432
EBITDA --
Operating profit (EBIT)1 496496
Operating Margin 34,6%34,6%
Pre-Tax Profit (EBT) --
Net income --
Net margin --
EPS2 0,420,45
Dividend per Share --
Announcement Date --
1 CNY in Million
2 CNY
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 ---3 4483 2384 507
Leverage (Debt / EBITDA) ----2,54x-1,40x-1,40x
Free Cash Flow -119----
ROE (Net Profit / Equities) 30,9%25,5%12,6%13,6%18,9%21,8%
Shareholders' equity1 1 4082 2525 4088 3199 66711 362
ROA (Net Profit / Asset) -15,8%-9,80%12,9%15,6%
Assets1 -3 644-11 55214 16015 878
Book Value Per Share2 2,874,2710,912,514,818,0
Cash Flow per Share2 0,540,780,641,111,352,43
Capex1 -3861 2269541 2861 539
Capex / Sales -19,9%54,2%27,3%23,0%21,0%
Announcement Date 02/26/201902/28/202004/29/2021---
1 CNY in Million
2 CNY
Key data
Capitalization (CNY) 74 459 228 150
Capitalization (USD) 11 527 980 825
Net sales (CNY) 2 261 177 380
Net sales (USD) 349 903 632
Number of employees 2 043
Sales / Employee (CNY) 1 106 793
Sales / Employee (USD) 171 270
Free-Float 96,9%
Free-Float capitalization (CNY) 72 130 903 356
Free-Float capitalization (USD) 11 167 503 229
Avg. Exchange 20 sessions (CNY) 867 444 303
Avg. Exchange 20 sessions (USD) 134 231 801
Average Daily Capital Traded 1,16%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA